Xcout Intel
Adela, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Adela, Inc. among diagnostics/tools companies — ranked by similarity to what Adela, Inc. actually does, not by market-cap band.
Subscribe to see Adela, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Adela, Inc.
Adela, Inc. is an epigenomics-focused biotechnology company headquartered in Foster City, California. The company is advancing breakthrough approaches for the early detection of multiple types of cancer through blood tests.
Adela, Inc. at a glance
Adela, Inc. is a diagnostics/tools company headquartered in United States, founded in 2020. Its most recent funding round raised $5M in April 2026. Xcout tracks 15 named people at Adela, Inc., including Priscilla Huang (Senior Vice President of Finance, Treasurer and Secretary).
Adela, Inc. leadership
- Priscilla HuangSenior Vice President of Finance, Treasurer and Secretary
- Alan WilliamsExecutive Officer
- Anne-Renee HartmanExecutive Officer
- Daniel Diniz De CarvalhoExecutive Officer
- David ScheerExecutive Officer
- Lindsay MateoExecutive Officer
9 more named people on record for Adela, Inc., with roles, board committees and tenure — see the full roster →
Adela, Inc. funding rounds
The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $25.4M | — | |
| SEC Form D filing | $3.3M | — | |
| SEC Form D filing | $48.5M | — | |
| SEC Form D filing | $1.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Adela, Inc. competitors
Ranked by semantic similarity — how close each company is to Adela, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers. Freenome's first commercial-stage test, SimpleScreen CRC for colorectal cancer, is under review by the U.S. Food and Drug Administration (FDA).
Biotech
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Healthcare
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA.
Biotechnology
Predicta Biosciences is a precision oncology company that builds a molecular insights platform for blood cancer care. By utilizing a single blood sample, the company integrates multiomics and liquid biopsies to generate longitudinal genomic and immune insights for diagnostics.
Medical Diagnostics, Biomedical Engineering, Liquid Biopsy
Nucleix is a liquid biopsy company headquartered in Rehovot, Israel. It aims to revolutionize cancer treatment through earlier disease detection, focusing on interventions that can bring the greatest impact.
Healthcare
GRAIL, Inc. is an innovative commercial-stage healthcare and life sciences company headquartered in Menlo Park, California, focused on early cancer detection technologies. The company was acquired by Illumina in 2021.
Biotechnology
Bellwether Bio, Inc. is a biotechnology company that develops next-generation cancer diagnostics using the epigenomic content of cell-free DNA to improve oncology patient care. Founded in 2016 and based in Seattle, Washington, the company was acquired by Guardant Health, Inc.
Biotechnology
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Biotechnology
SAGA Diagnostics provides ultra-sensitive, blood-based molecular residual disease (MRD) detection and monitoring tests for cancer patients. The company's flagship platform, Pathlight, uses tumor whole-genome sequencing and personalized digital PCR assays to detect circulating tumor DNA, primarily serving clinicians and biopharmaceutical partners for early cancer detection and treatment tracking.
Diagnostics
DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Diagnostics
Elypta AB is a private biotech company headquartered in Solna, Sweden, operating on the Karolinska Institute campus. The firm focuses on developing cancer detection tests based on metabolism and liquid biopsy biomarkers.
Diagnostics
Naveris, Inc. is a biotechnology research and cancer detection company located in Waltham, Massachusetts. It specializes in developing advanced molecular diagnostic blood tests for HPV-associated cancers.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Adela, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Adela, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →